Evolving Safety Models: Integrating In Silico Insights & Tailored In Vitro Approaches for Smarter Early Target & Candidate Prioritization

• Target safety and in silico alerts: leverage data and mechanistic insights to identify hazards linked to target biology or chemical structure before synthesis
• Tailored in vitro models: beyond standard screens to understand toxicity drivers and prioritize candidates with the lowest risk
• De-risk earlier with confidence: integrate early data into a decision strategy to reduce attrition and accelerate decision

Speakers:

Natalie Ketter

Director & Head of Investigative Toxicology

Boehringer Ingelheim